Abstract
We describe the case of a boy who presented with abdominal Burkitt lymphoma; he had been regularly using tacrolimus ointment 0.1% for severe recurrent atopic dermatitis for 7 years immediately prior to developing cancer. We present his medical history and review the current knowledge regarding a link between topical tacrolimus and malignancy risk.
Original language | English |
---|---|
Pages (from-to) | 117-120 |
Number of pages | 4 |
Journal | Cutis |
Volume | 89 |
Issue number | 3 |
State | Published - Mar 2012 |
ASJC Scopus subject areas
- Dermatology